Egypt

Study populations

Egypt, in 2016, had an estimated population of 93.2m with 33% under the age of 15 years (47m) and 5% over the age of 65 years (8.1m). By 2050, the population distribution will have changed considerably with 10% (15.7m) of the population being in the older age group, even though younger people will still represent over a quarter of the population.

Alongside the ageing population diabetes prevalence is increasing – with the most recent statistics reporting 7.8m people living with the condition and by 2040, the estimate is 15.1m. There are an estimated 3.2m undiagnosed cases.

Report & Infographic

Cover page for Egypt Study Report. For accessible PDF version of full report click the image.
Info-graphic containing overview of findings. For an accessible PDF please click the image.

Percentage of health care providers who share patient data with other health care providers to optimize patient care

50% Yes, 50% No, 0% Don't Know
(Opthamologists n=14)
Yes
 No
 Don't Know

Percentage of adults with diabetes who have completed an eye exam

49.3% Have had an eye exam, 50.7% Never had an eye exam
(Adults with diabetes n=75)
Have had an eye exam
 Never had an eye exam
  

Availability of DR patient education materials in health care providers’ offices

26.7% Sufficient information available, 20% Information not sufficient, 53.3% No written information available, 0% Don’t know
(All providers n=15)
Sufficient information available Information not sufficient No written information available Don’t know

Frequency of discussions about eye complications with health care providers

20% Every visit, 25.3% Multiple times per year, 16% Once a year, 16% When symptoms arise, 21.3% Never
(Adults with diabetes n=75)
Every visit Multiple times per year Once a year When symptoms arise Never
banner-join-community
Join the DR Community

The DR Barometer Community is a growing multidisciplinary network of thought leaders and organizations who are working together to address gaps in diabetes patient care. Join today to help improve vision health outcomes among people living with diabetes.